GlobeNewswire

Compuware Topaz Removes Go-To-Market Friction by Giving DevOps Fast, Efficient and Secure Access to Enterprise Data

Dela

Advanced Data Visualization, Masking and Conversion  Ensure Agile, Compliant Delivery of Apps and Analytics

  • Enterprises often find themselves unable to tap the full potential business value of their diverse data because DevOps teams can't get all the data they need, when they need it, in the format they require.
     
  • Compuware Topaz for Enterprise Data takes labor, complexity and risk out of the data-to-value pipeline with powerful extraction, masking and visualization for the mainframe and other platforms.
     
  • With Topaz for Enterprise Data, enterprises can empower DevOps staff across skill/experience levels to more quickly, efficiently and securely leverage all available data sources to deliver high-value apps and analytics.

DETROIT, June 28, 2018 (GLOBE NEWSWIRE) -- Compuware today released the new Topaz for Enterprise Data, which provides a powerful combination of data visualization, extract and load, and advanced data masking capabilities. With it, DevOps teams can more quickly, efficiently and securely access and leverage data from the mainframe and other platforms.

Fast, streamlined access to high-value data has become an urgent concern as businesses seek competitive advantages in a digital economy, while fulfilling increasingly stringent compliance requirements. Topaz for Enterprise Data empowers developers, QA staff, operations teams and data scientists at all skill and experience levels to ensure they have immediate, secure access to the data they need, when they need it, in any format required.

Data masking is a top concern, given the importance of protecting personally identifiable information (PII) and complying with regulatory mandates such as GDPR-even during development and testing, especially when outsourcing these functions.

Topaz for Enterprise Data's capabilities are particularly important for enterprises with large, diverse datasets of high business value residing on the mainframe that contain sensitive business or personal information. As senior mainframe professionals retire, large enterprises must transfer responsibility for stewardship of this data to a new generation of DevOps artisans with less hands-on mainframe experience.

Topaz for Enterprise Data empowers these artisans to:

  • Readily understand relationships between data even when they lack direct familiarity with specific data types or applications, to ensure data integrity and resulting code quality.
  • Quickly generate data for testing, training or business analytics purposes that properly and accurately represents actual production data.
  • Ensure that any sensitive business or personal data extracted from production is properly masked for privacy and compliance purposes, while preserving essential data relationships and characteristics.
  • Convert file type as required.

Topaz users can access all these capabilities from within a familiar Eclipse development environment.

"Testing with production-like obfuscated data helps us develop and deliver better quality applications, as well as remain compliant with data privacy requirements," said Lynn Farley, Manager of Data Management at TCF Bank. "Topaz provides our developers with a way to implement data privacy rules to obfuscate multiple data types across platforms and with consistent results."

"Leveraging a modern interface for fast, simple access to data for testing and other purposes is critical to digital agility," said Rich Ptak of IT analyst firm Ptak Associates. "The latest version of Compuware Topaz for Enterprise Data delivers a benefits trifecta to resolve the long-standing challenge of rapidly getting value from the reams of data from disparate sources and formats that are critical to DevOps and continuous improvement."

Today's announcement marks the 15th consecutive quarter that Compuware has delivered essential innovation to help large enterprises master Agile and DevOps tasks on a mainstreamed mainframe, so they can best leverage the platform's unmatched performance, scalability, reliability, efficiency and security.

"The wealth of data that should give large enterprises a major competitive advantage in the digital economy often instead becomes a hindrance due to the complexity of sourcing across platforms, databases and formats," said Chris O'Malley, CEO of Compuware. "With Topaz for Enterprise Data, Compuware is removing these hindrances-so there's far less friction between enterprise data and business wins."

Compuware Corporation
Compuware empowers the world's largest companies to excel in the digital economy by fully leveraging their high-value mainframe investments. We do this by delivering highly innovative solutions that uniquely enable IT professionals with mainstream skills to manage mainframe applications, data, and platform operations. Learn more at compuware.com.

Follow us on:

Press Contact
Frank Cioffi, The Medialink Group, frankc@medialinkgroup.com, (415) 893-1570
Kristina LeBlanc, The Medialink Group, kristinawleblanc@gmail.com, (508) 930-5636
Mary McCarthy, Public Relations Manager, Compuware, mary.mccarthy@compuware.com, (313) 227-7088

For Sales and Marketing Information
Compuware Corporation, One Campus Martius, Detroit MI 48226, 800-266-7892, www.compuware.com.

Copyright © 2018, Compuware Corporation. All rights reserved. The Compuware products and services listed within this release are trademarks or registered trademarks of Compuware Corporation.




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Compuware Corporation via Globenewswire

Om

GlobeNewswire



Följ GlobeNewswire

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från GlobeNewswire

Karolinska Development's portfolio company Modus Therapeutics completes enrollment in Phase II study with sevuparin7.1.2019 12:00Pressmeddelande

STOCKHOLM, January 7, 2019. Karolinska Development's portfolio company Modus Therapeutics announces that the patient enrollment has been completed in the Phase II study with sevuparin in patients with sickle cell disease (SCD). The results from the study is expected in mid 2019. Modus Therapeutic's randomized, double blind study contains 140 SCD-patients with Acute Vaso Occlusive Crisis (VOC). It compares intravenously administered sevuparin with placebo. The primary endpoint of the study is the demonstration of a reduced time to resolution of patient's VOC. Clincal sites across Europe and the Middle East took part in the study that was conducted in conjunction with Modus Therapeutics' co development partner Ergomed. SCD has a high unmet medical need as there are currently no approved therapies for VOCs. It is an inherited blood disorder that affects between 90,000 to 100,000 patients in the U.S. and is characterized by severely painful VOCs that lead to organ damage due to a lack of o

Karolinska Development's portfolio company Modus Therapeutics completes enrollment in Phase II study with sevuparin7.1.2019 12:00Pressmeddelande

STOCKHOLM, January 7, 2019. Karolinska Development's portfolio company Modus Therapeutics announces that the patient enrollment has been completed in the Phase II study with sevuparin in patients with sickle cell disease (SCD). The results from the study is expected in mid 2019. Modus Therapeutic's randomized, double blind study contains 140 SCD-patients with Acute Vaso Occlusive Crisis (VOC). It compares intravenously administered sevuparin with placebo. The primary endpoint of the study is the demonstration of a reduced time to resolution of patient's VOC. Clincal sites across Europe and the Middle East took part in the study that was conducted in conjunction with Modus Therapeutics' co development partner Ergomed. SCD has a high unmet medical need as there are currently no approved therapies for VOCs. It is an inherited blood disorder that affects between 90,000 to 100,000 patients in the U.S. and is characterized by severely painful VOCs that lead to organ damage due to a lack of o

Stillfront Group rekryterar ansvarig för M&A19.12.2018 12:07Pressmeddelande

PRESSMEDDELANDE 19 december, 2018 Stillfront Group rekryterar ansvarig för M&A Stillfront Group, en marknadsledare inom 'free to play' online strategispel, annonserar idag att Marina Andersson har utsetts till ansvarig för M&A och kommer att ingå i koncernledningen. Marina har närmare tjugo års erfarenhet från investment banking och M&A. Hon har omfattande erfarenhet inom strategisk och finansiell rådgivning, affärsgenerering, projektledning inom förvärv och försäljningar av företag, finansiell analys, due diligence, samt företagsvärdering. Tidigare positioner inkluderar: Director, Deloitte's Corporate Finance Advisory team, Director, ICECAPITAL Securities, Associate Partner och Investment Manager, Deseven, samt M&A Analytiker på Carnegie. Marina har två magister-examen från Stockholms universitet och Russian Herzen State Pedagogical University. "Förvärv är en viktig del av Stillfronts affärsstrategi och vi är mycket glada att rekrytera Marina Andersson. Marinas breda erfarenhet och pr

Stillfront Group announces Head of M&A19.12.2018 12:07Pressmeddelande

PRESS RELEASE December 19, 2018 Stillfront Group announces Head of M&A Stillfront Group, a market leader in 'free to play' online strategy games, today announces that Marina Andersson has been appointed as Head of M&A and will be part of the Group's management team. Marina has close to 20 years track record of investment banking and M&A. She has extensive competence within strategic and financial advisory, deal generation, buy and sell side M&A project management, financial analysis, due diligence and company valuation. Former positions include: Director at Deloitte's Corporate Finance Advisory team, Director at ICECAPITAL Securities, Associate Partner and Investment Manager at Deseven, M&A Analyst at Carnegie. She holds two Master degrees from Stockholm University and Russian Herzen State Pedagogical University. "Acquisitions are a crucial part of Stillfront's business strategy and we are very pleased with the appointment of Marina Andersson. Marina's breadth of experience and profess

Oboya tecknar ett samarbetsavtal med Gaia avseende biomaterial13.12.2018 11:41Pressmeddelande

Oboya Horticulture Industries AB (publ) ("Oboya") har tecknat ett viktigt och långsiktigt samarbetsavtal avseende miljövänligt biomaterial med Gaia Biomaterials AB ("Gaia") i Helsingborg, Sverige. Avtalet innebär att Oboya använder Gaias biomaterial för tillverkning och utveckling av miljövänliga odlingsprodukter till odlingsindustrin. Oboya har under de senaste åren arbetat aktivt med innovation, miljö- och hållbarhetsfrågor och vårt mål är att främja miljö och hållbarhet inom odlingsindustrin genom att erbjuda miljövänliga odlingsprodukter till våra kunder. Oboya anser att användningen av biomaterial kommer att vara viktigt för framgång i omställningen till en fossilfri odlingsindustri världen över. Samarbetsavtalet innebär att Oboya använder Gaias biomaterial i sin produktion och att vi genom Gaias kompetens kan utveckla nya miljövänliga odlingsprodukter. Gaias biomaterial är biologiskt nedbrytbart, komposterbart samt ger upp till 80 % lägre koldioxidutsläpp vid förbränning jämfört

Oboya signs a cooperation agreement with Gaia regarding biomaterials13.12.2018 11:41Pressmeddelande

Oboya Horticulture Industries AB (publ) ("Oboya") has signed an important and long-term cooperation agreement on environmentally friendly biomaterials with Gaia Biomaterials AB ("Gaia") in Helsingborg, Sweden. The agreement means that Oboya uses Gaias biomaterials for the production and development of environmentally friendly cultivation products for the cultivation industry. Oboya has been actively involved in innovation, environmental and sustainability issues in recent years, and our goal is to encourage environmental and sustainability in the cultivation industry by offering environmentally friendly cultivation products to our customers. Oboya believes that the use of biomaterials will be important for success in the conversion to a fossil-free cultivation industry worldwide. The cooperation agreement means that Oboya uses Gaias biomaterials in its production and that through Gaias expertise we can develop new environmentally friendly cultivation products. Gaias biomaterials are bi

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum